Glucagon: Revision history

22 September 2019

• curprev 20:1320:13, 22 September 2019‎ ClaireLewis talk contribs‎ 2,071 bytes +80‎ No edit summary

2 May 2019

• curprev 04:4604:46, 2 May 2019‎ Rossdonaldson1 talk contribs‎ 1,991 bytes +9‎ No edit summary

2 April 2019

• curprev 19:2419:24, 2 April 2019‎ Wgalvin85 talk contribs‎ 1,982 bytes +82‎ →‎References: added
• curprev 19:2419:24, 2 April 2019‎ Wgalvin85 talk contribs‎ 1,900 bytes +148‎ →‎Special Populations: added

27 August 2018

• curprev 10:0310:03, 27 August 2018‎ Josgood talk contribs‎ 1,752 bytes +22‎ →‎Food bolus impaction

27 February 2018

• curprev 10:2810:28, 27 February 2018‎ Rossdonaldson1 talk contribs‎ 1,730 bytes 0‎ →‎Food Bolus Impaction

12 February 2018

• curprev 19:0219:02, 12 February 2018‎ DrKarb talk contribs‎ 1,730 bytes +44‎ →‎Adult Dosing

13 October 2017

• curprev 15:1515:15, 13 October 2017‎ ELEE1987 talk contribs‎ 1,686 bytes +105‎ →‎Pharmacology
• curprev 15:1315:13, 13 October 2017‎ ELEE1987 talk contribs‎ 1,581 bytes +38‎ →‎Common
• curprev 15:1315:13, 13 October 2017‎ ELEE1987 talk contribs‎ 1,543 bytes +56‎ →‎Serious
• curprev 15:1215:12, 13 October 2017‎ ELEE1987 talk contribs‎ 1,487 bytes +32‎ →‎Contraindications

20 July 2016

• curprev 22:2422:24, 20 July 2016‎ Neil.m.young talk contribs‎ 1,455 bytes −1‎ Text replacement - "3 mg" to "3mg"

19 July 2016

• curprev 06:3906:39, 19 July 2016‎ Neil.m.young talk contribs‎ 1,456 bytes −1‎ Text replacement - "1 mg" to "1mg"

26 June 2016

• curprev 15:2815:28, 26 June 2016‎ Neil.m.young talk contribs‎ 1,457 bytes +3‎ Text replacement - "==Sources==" to "==References=="

9 May 2016

• curprev 02:1602:16, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,454 bytes +8‎ →‎General
• curprev 02:1502:15, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,446 bytes −5‎ →‎Beta-blocker toxicity
• curprev 02:1402:14, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,451 bytes +66‎ →‎Adult Dosing
• curprev 02:1302:13, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,385 bytes +4‎ →‎Hypoglycemia
• curprev 02:1302:13, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,381 bytes −3‎ →‎Hypoglycemia
• curprev 02:1202:12, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,384 bytes +107‎ →‎Hypoglycemia
• curprev 02:0802:08, 9 May 2016‎ Rossdonaldson1 talk contribs‎ 1,277 bytes +78‎ →‎Pediatric Dosing

22 March 2016

• curprev 15:5415:54, 22 March 2016‎ Ostermayer talk contribs‎ 1,199 bytes +7‎ Text replacement - "Category:Drugs" to "Category:Pharmacology"

8 March 2015

• curprev 18:2618:26, 8 March 2015‎ Rossdonaldson1 talk contribs‎ 1,192 bytes −208‎ →‎Sources
• curprev 18:2618:26, 8 March 2015‎ Rossdonaldson1 talk contribs‎ 1,400 bytes +24‎ →‎Beta-blocker toxicity
• curprev 18:2518:25, 8 March 2015‎ Rossdonaldson1 talk contribs‎ 1,376 bytes +15‎ /* Beta-blocker toxicityKerns W. Management of beta-adrenergic blocker and calcium channel antagonist toxicity. Emerg Med Clin North Am. 2007;25(2):309-331. (Review) Bailey B (2003). Glucagon in beta-blocker and calcium channel blocker overdoses: a sys...
• curprev 18:2418:24, 8 March 2015‎ Rossdonaldson1 talk contribs‎ 1,361 bytes +772‎ No edit summary
• curprev 18:1918:19, 8 March 2015‎ Rossdonaldson1 talk contribs‎ 589 bytes +5‎ →‎Betablocker Reversal

19 December 2014

• curprev 21:4921:49, 19 December 2014‎ Rossdonaldson1 talk contribs‎ 584 bytes +584‎ Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: ==Adult Dosing== ===Betablocker Reversal=== *1-2mg IV over 5 minutes **followed by infusion of 5 - 15 µg/min ==Ped..."